Woods, Beth S., Sideris, Eleftherios, Sydes, Matthew R., Gannon, Melissa R., Parmar, Mahesh K.B., Alzouebi, Mymoona, Attard, Gerhardt, Birtle, Alison J., Brock, Susannah, Cathomas, Richard, Chakraborti, Prabir R., Cook, Audrey, Cross, William R., Dearnaley, David P., Gale, Joanna, Gibbs, Stephanie, Graham, John D., Hughes, Robert, Jones, Rob J., Laing, Robert, Mason, Malcolm D., Matheson, David, McLaren, Duncan B., Millman, Robin, O'Sullivan, Joe M., Parikh, Omi, Parker, Christopher C., Peedell, Clive, Protheroe, Andrew, Ritchie, Alastair W.S., Robinson, Angus, Russell, J. Martin, Simms, Matthew S., Srihari, Narayanan N., Srinivasan, Rajaguru, Staffurth, John N., Sundar, Santhanam, Thalmann, George N., Tolan, Shaun, Tran, Anna T.H., Tsang, David, Wagstaff, John, James, Nicholas D. and Sculpher, Mark J.
2018.
Addition of Docetaxel to first-line long-term hormone therapy in prostate cancer (STAMPEDE): Modelling to estimate long-term survival, quality-adjusted survival, and cost-effectiveness.
European Urology Oncology
1
(6)
, pp. 449-458.
10.1016/j.euo.2018.06.004
|
|
PDF
- Published Version
Available under License Creative Commons Attribution. Download (866kB) | Preview |
Official URL: http://dx.doi.org/10.1016/j.euo.2018.06.004
| Item Type: | Article |
|---|---|
| Date Type: | Publication |
| Status: | Published |
| Schools: | Medicine |
| ISSN: | 2588-9311 |
| Date of First Compliant Deposit: | 1 August 2019 |
| Date of Acceptance: | 12 June 2018 |
| Last Modified: | 03 Aug 2019 23:27 |
| URI: | http://orca.cf.ac.uk/id/eprint/124638 |
Actions (repository staff only)
 |
Edit Item |
Altmetric
Altmetric
Cardiff University Information Services